A Ortega-Moreno

974 total citations
10 papers, 741 citations indexed

About

A Ortega-Moreno is a scholar working on Neurology, Cellular and Molecular Neuroscience and Rheumatology. According to data from OpenAlex, A Ortega-Moreno has authored 10 papers receiving a total of 741 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Neurology, 3 papers in Cellular and Molecular Neuroscience and 2 papers in Rheumatology. Recurrent topics in A Ortega-Moreno's work include Neurological disorders and treatments (5 papers), Parkinson's Disease Mechanisms and Treatments (4 papers) and Peripheral Neuropathies and Disorders (2 papers). A Ortega-Moreno is often cited by papers focused on Neurological disorders and treatments (5 papers), Parkinson's Disease Mechanisms and Treatments (4 papers) and Peripheral Neuropathies and Disorders (2 papers). A Ortega-Moreno collaborates with scholars based in Spain and United Kingdom. A Ortega-Moreno's co-authors include Julio Pardo, Eduard Gallardo, María J. Sedano, Isabel Illa, Luís Querol, Jordi Díaz‐Manera, Adolfo Mínguez‐Castellanos, Francisco Escamilla‐Sevilla, Rafael Blesa and Gisela Nogales‐Gadea and has published in prestigious journals such as Neurology, Journal of Neurology Neurosurgery & Psychiatry and Movement Disorders.

In The Last Decade

A Ortega-Moreno

10 papers receiving 714 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Ortega-Moreno Spain 6 656 420 110 83 61 10 741
Constance Manso France 9 683 1.0× 562 1.3× 150 1.4× 110 1.3× 85 1.4× 9 855
Yumi Fujimaki Japan 17 730 1.1× 346 0.8× 113 1.0× 116 1.4× 122 2.0× 25 935
Julio Pardo Spain 15 698 1.1× 553 1.3× 122 1.1× 71 0.9× 192 3.1× 27 1.0k
Penny F Atkinson United Kingdom 10 366 0.6× 286 0.7× 68 0.6× 121 1.5× 53 0.9× 11 538
Hidenori Ogata Japan 15 792 1.2× 857 2.0× 182 1.7× 103 1.2× 83 1.4× 40 1.2k
Angela Jochim Germany 15 309 0.5× 176 0.4× 85 0.8× 64 0.8× 150 2.5× 27 614
Hanspeter E. Killer Switzerland 15 345 0.5× 164 0.4× 69 0.6× 68 0.8× 68 1.1× 35 607
Abdolmohammad Rostami United States 14 225 0.3× 232 0.6× 43 0.4× 56 0.7× 103 1.7× 24 499
Hjörvar Pétursson Iceland 3 338 0.5× 232 0.6× 148 1.3× 66 0.8× 285 4.7× 4 877
Heather Waddy Australia 10 474 0.7× 360 0.9× 57 0.5× 23 0.3× 69 1.1× 13 558

Countries citing papers authored by A Ortega-Moreno

Since Specialization
Citations

This map shows the geographic impact of A Ortega-Moreno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Ortega-Moreno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Ortega-Moreno more than expected).

Fields of papers citing papers by A Ortega-Moreno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Ortega-Moreno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Ortega-Moreno. The network helps show where A Ortega-Moreno may publish in the future.

Co-authorship network of co-authors of A Ortega-Moreno

This figure shows the co-authorship network connecting the top 25 collaborators of A Ortega-Moreno. A scholar is included among the top collaborators of A Ortega-Moreno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Ortega-Moreno. A Ortega-Moreno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Querol, Luís, Ricard Rojas‐García, Jordi Díaz‐Manera, et al.. (2015). Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins. Neurology Neuroimmunology & Neuroinflammation. 2(5). e149–e149. 200 indexed citations
2.
Querol, Luís, Gisela Nogales‐Gadea, Ricardo Rojas‐García, et al.. (2014). Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg. Neurology. 82(10). 879–886. 276 indexed citations
3.
Escamilla‐Sevilla, Francisco, et al.. (2009). [Diagnostic value of cardiac 123I-metaiodobenzylguanidine (123I-MIBG) scintigraphy in Lewy body disorders].. PubMed. 24(3). 170–6. 9 indexed citations
4.
Mínguez‐Castellanos, Adolfo, Francisco Escamilla‐Sevilla, Gary Hotton, et al.. (2007). Carotid body autotransplantation in Parkinson disease: a clinical and positron emission tomography study. Journal of Neurology Neurosurgery & Psychiatry. 78(8). 825–831. 72 indexed citations
5.
Mínguez‐Castellanos, Adolfo, Francisco Escamilla‐Sevilla, A Ortega-Moreno, et al.. (2007). Do α-synuclein aggregates in autonomic plexuses predate Lewy body disorders?. Neurology. 68(23). 2012–2018. 150 indexed citations
6.
Ortega-Moreno, A, et al.. (2007). [Sign of hyperdense and hyperintense anterior cerebral artery].. PubMed. 22(3). 184–6. 3 indexed citations
7.
Escamilla‐Sevilla, Francisco, et al.. (2005). Valor de los signos de cápsula interna en la estimulación del núcleo subtalámico de la enfermedad de Parkinson. Revista de Neurología. 41(4). 193–193. 1 indexed citations
8.
Escamilla‐Sevilla, Francisco, et al.. (2004). [Clinical utility of deep brain stimulation in an advanced Parkinson's disease].. PubMed. 19(10). 719–27. 2 indexed citations
9.
Mínguez‐Castellanos, Adolfo, et al.. (1999). Primary writing tremor treated by chronic thalamic stimulation. Movement Disorders. 14(6). 1030–1033. 27 indexed citations
10.
Ortega-Moreno, A, et al.. (1998). Actividad y costes por GRD del Servicio de Neurología del Hospital Universitario Virgen de las Nieves de Granada. Revista de Neurología. 27(157). 453–453. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026